Endoscopy, the standard for detecting esophageal precancer, is quite an invasive procedure — so a lot of people who should be screened end up never being tested. Lucid Diagnostics is trying to solve this problem by selling a quick, office-based diagnostic.
BridgeBio Pharma claims its drug, Attruby, has an edge over a Pfizer drug as a treatment for cardiomyopathy caused by transthyretin-mediated amyloidosis. But new competition to both products could come soon from Alnylam Pharmaceuticals, now set to receive an FDA decision in this indication by late March.
A single source for provider credentialing would involve creating a centralized, continuously updated database of credentialing information that could be accessed and trusted across the healthcare sector. While no such system exists today, it should be the goal, and here's why.
In this episode, we do a wrap up of the annual HLTH conference and we discuss topics like artificial intelligence, primary care and GLP-1s. Companies we talk about are Amazon One Medical, Noom Health, GE Healthcare, Cleveland Clinic.
No comments